Previous close | 26.68 |
Open | 26.68 |
Bid | 30.50 |
Ask | 35.40 |
Strike | 30.00 |
Expiry date | 2024-05-17 |
Day's range | 26.68 - 26.68 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH for prostates of all sizesSAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced long-term, real-world data sho
PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) just released its latest quarterly results and things are looking...
On May 1, 2024, Thomas Krummel, Director at PROCEPT BioRobotics Corp (NASDAQ:PRCT), sold 20,000 shares of the company.